SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pied Piper who wrote (1131)6/14/1999 2:27:00 AM
From: Wisee  Read Replies (1) of 1185
 
As shareholders of a company, we all get hurt when a deal falls through. Many times large pharma co. pull out of agreements in various stages of drug development. That does not mean the drugs tested are no good, only that their priorities have changed.
We must remember biotechs are long term investments (3 to 5 years minimum).

Nortran has come a long way. Their cough program (drug CPI) which has a $1.6 billion market is currently in final preclinical stage. Phase I and II of this cough program are scheduled for this month, with results by August/99. Note the Drug CPI has previously been proven safe in humans.

The local anestetic drug is in Phase II and going into Phase III clinical trials.

The antiarrhythmics program is well advanced and at present Astra Zeneca (a much larger pharmaceutical company than Roche) has an agreement with Nortran. Astra is continuing further talks in regards to these drugs and other drugs in Nortran.
Roche was involved in part of the antiarrhythmic program where they were only testing four molecules of over 200 molecules that Nortran owns.

How many small biotech companies are in clinical Phase II with their drugs? How many drugs do they have in their pipelines?

I state my position as being only a long term shareholder of Nortran and nothing else.

Short term pain and long term gain.

Wisee

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News